Modern methods in the diagnosis of leukemia;Moderne verfahren in der leukämiediagnostik

Internist

Volumn 43, Issue 10, 2002, Pages 1190-1202

  Haferlach, T ^a,b   Schoch, C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; CANCER DIAGNOSIS; CELL STRUCTURE; CHROMOSOME BANDING PATTERN; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOCHEMISTRY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOLOGY; IMMUNOPHENOTYPING; POLYMERASE CHAIN REACTION; REVIEW; BLOOD CELL; BONE MARROW CELL; CHROMOSOME ANALYSIS; CHROMOSOME MAP; CLASSIFICATION; COMPARATIVE STUDY; GENETICS; KARYOTYPING; LEUKEMIA; PATHOLOGY; PREDICTION AND FORECASTING; PROGNOSIS;

BLOOD CELLS; BONE MARROW CELLS; CHROMOSOME MAPPING; CYTOGENETIC ANALYSIS; HUMANS; KARYOTYPING; LEUKEMIA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 0036824604     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-002-0704-8     Document Type: Review

References (28)

1. Bennett JM, Catovsky D, Daniel MT et al. (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. Br J Haematol 33: 451-458
2. Bennett JM, Catovsky D, Daniel MT et al. (1985) Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103: 620-625
3. Harris NL, Jaffe ES, Diebold J et al. (1999) World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissue: report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 17: 3835-3849
4. Jaffe ES, Harris NL, Stein H, Vardiman J (eds) (2001) World Health Organization of Tumors, Pathology & Genetics, Tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon
5. Haferlach T, Schoch C (2002) WHO-Klassifikation der akuten myeloischen Leukämien (AML) und der myelodysplastischen Syndrome (MDS). Dtsch Med Wochenschr 127: 447-450
6. Löffler H, Rastetter J (1999) Atlas der klinischen Hämatologie, 5. Aufl. Springer, Berlin Heidelberg New York Tokio
7. Ludwig WD, Haferlach T, Schoch C (2002) Classification of acute leukemias. In: Pui CH (ed) Acute Leukemias. (in press)
8. Bennett JM, Catovsky D, Daniel MT et al. (1985) Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). Ann Intern Med 103: 460-462
9. Bennett JM, Catovsky D, Daniel MT et al. (1991) Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-M0). Br J Haematol 78: 325-329
10. Béné MC, Bernier M, Casanovas RO et al. (2001) Acute myeloid leukemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients. Br J Haematol 113: 737-745
11. Béné MC, Castoldi G, Knapp W et al. (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9: 1783-1786
12. Mitelman F (ed) (1995) ISCN 1995, Guidelines for cancer cytogenetics. Supplement to: An international system for human cytogenetic nomenclature. Karger, Stuttgart
13. Speicher MR, Ward DC (1996) The coloring of cytogenetics. Nature Med 2: 1046-1048
14. Speicher MR, Ballard SG, Ward DC (1996) Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nature Genet 12: 368-375
15. Schröck E, du Manoir S, Veldman T et al. (1996) Multicolor spectral karyotyping of human chromosomes. Science 273: 494-497
16. du Manoir S, Speicher MR, Joos S et al. (1993) Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90: 590-610
17. Kallioniemi OP, Kallioniemi A, Piper J et al. (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243
18. Ellis M, Ravid M, Lishner M (1993) A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias. Leuk Lymphoma 11: 9-13
19. van Dongen JJM, Seriu T, Panzer-Grünmayer ER et al. (1998) Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 352: 1731-1738
20. Druker B, Talpaz M, Resta DJ et al. (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344: 1031-1037
21. Huntly BJP, Reid AG, Bench AJ et al. (2001) Deletions of the derivative chromosome 9 occur at the time of Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 98: 1732-1738
22. Kolomietz E, Al-Maghrabi J, Brennan S et al. (2001) Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submikroskopic deletions and may lead to altered prognosis. Blood 97: 3581-3588
23. Sinclair PB, Nacheva EP, Leversha M et al. (2000) Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95: 738-744
24. Schoch C, Schnittger S, Bursch S et al. (2002) Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: A study on 350 cases. Leukemia 16: 53-59
25. Cross NC (1998) Minimal residual disease in chronic myeloid leukaemia. Hematol Cell Ther 40: 224-228
26. Döhner H, Stilgenbauer S, Benner A et al. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343: 1910-1916
27. Hofmann WK, de Vos S, Elashoff D et al. (2002) Relation between resistance of Philadelphia-chromosome-positive acute lymphoblastic leukaemia to the tyrosine kinase inhibitor STI571 and gene-expression profiles: a gene-expression study. Lancet 359: 458-459
28. Schoch C, Kohlmann A, Schnittger S et al. (2002) Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles. Proc Natl Acad Sci (in press)